Overview

Franklin Genomic Advancements ETF (HELX) is managed by Franklin Templeton. The fund was launched on 2020-02-25 and trades on the Cboe BZX U.S. Equities Exchange.

Fund Details

  • Category: Growth
  • General Category: Sector Equity
  • Expense Ratio: 0.00%
  • Assets Under Management: $11M
  • Actively Managed: Yes
  • SEC CIK Code: 0001655589
  • Benchmark: Russell 3000

Investment Strategy

This Sector Equity fund is actively managed and tracks the Russell 3000.